These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9582014)

  • 1. In B16 melanoma cells, the inhibition of melanogenesis by TPA results from PKC activation and diminution of microphthalmia binding to the M-box of the tyrosinase promoter.
    Bertolotto C; Bille K; Ortonne JP; Ballotti R
    Oncogene; 1998 Apr; 16(13):1665-70. PubMed ID: 9582014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of density-dependent regulation of the tyrosinase gene promoter: role of protein kinase C.
    Mahalingam H; Watanabe A; Tachibana M; Niles RM
    Exp Cell Res; 1997 Nov; 237(1):83-92. PubMed ID: 9417870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TFE3, a transcription factor homologous to microphthalmia, is a potential transcriptional activator of tyrosinase and TyrpI genes.
    Verastegui C; Bertolotto C; Bille K; Abbe P; Ortonne JP; Ballotti R
    Mol Endocrinol; 2000 Mar; 14(3):449-56. PubMed ID: 10707962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product.
    Bertolotto C; Bille K; Ortonne JP; Ballotti R
    J Cell Biol; 1996 Aug; 134(3):747-55. PubMed ID: 8707852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of microphthalmia transcription factor in regulation of melanocyte differentiation marker TRP-1.
    Fang D; Setaluri V
    Biochem Biophys Res Commun; 1999 Mar; 256(3):657-63. PubMed ID: 10080955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor alpha-mediated inhibition of melanogenesis is dependent on nuclear factor kappa B activation.
    Englaro W; Bahadoran P; Bertolotto C; Buscà R; Dérijard B; Livolsi A; Peyron JF; Ortonne JP; Ballotti R
    Oncogene; 1999 Feb; 18(8):1553-9. PubMed ID: 10102625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of melanogenesis in B16 mouse melanoma cells by protein kinase C.
    Mahalingam H; Vaughn J; Novotny J; Gruber JR; Niles RM
    J Cell Physiol; 1996 Sep; 168(3):549-58. PubMed ID: 8816909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia.
    Bertolotto C; Buscà R; Abbe P; Bille K; Aberdam E; Ortonne JP; Ballotti R
    Mol Cell Biol; 1998 Feb; 18(2):694-702. PubMed ID: 9447965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of melanogenesis inhibition by 2,5-dimethyl-4-hydroxy-3(2H)-furanone.
    Lee J; Jung E; Lee J; Huh S; Boo YC; Hyun CG; Kim YS; Park D
    Br J Dermatol; 2007 Aug; 157(2):242-8. PubMed ID: 17650175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guggulsterone inhibits melanogenesis in B16 murine melanoma cells by downregulating tyrosinase expression.
    Koo JH; Rhee KS; Koh HW; Jang HY; Park BH; Park JW
    Int J Mol Med; 2012 Oct; 30(4):974-8. PubMed ID: 22797252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microphthalmia associated transcription factor is a target of the phosphatidylinositol-3-kinase pathway.
    Khaled M; Larribere L; Bille K; Ortonne JP; Ballotti R; Bertolotto C
    J Invest Dermatol; 2003 Oct; 121(4):831-6. PubMed ID: 14632202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2, 3, 5, 4'-tetrahydroxystilbene-2-O-beta-D-glucoside (THSG) induces melanogenesis in B16 cells by MAP kinase activation and tyrosinase upregulation.
    Jiang Z; Xu J; Long M; Tu Z; Yang G; He G
    Life Sci; 2009 Aug; 85(9-10):345-50. PubMed ID: 19527735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma.
    Sato K; Toriyama M
    J Dermatol Sci; 2009 Feb; 53(2):140-5. PubMed ID: 19013771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mangosteen leaf extract increases melanogenesis in B16F1 melanoma cells by stimulating tyrosinase activity in vitro and by up-regulating tyrosinase gene expression.
    Hamid MA; Sarmidi MR; Park CS
    Int J Mol Med; 2012 Feb; 29(2):209-17. PubMed ID: 22089762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel adamantyl benzylbenzamide derivative, AP736, suppresses melanogenesis through the inhibition of cAMP-PKA-CREB-activated microphthalmia-associated transcription factor and tyrosinase expression.
    Lee CS; Jang WH; Park M; Jung K; Baek HS; Joo YH; Park YH; Lim KM
    Exp Dermatol; 2013 Nov; 22(11):762-4. PubMed ID: 24107097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Angelica gigas extract on melanogenesis in B16 melanoma cells.
    Lv N; Koo JH; Yoon HY; Yu J; Kim KA; Choi IW; Kwon KB; Kwon KS; Kim HU; Park JW; Park BH
    Int J Mol Med; 2007 Nov; 20(5):763-7. PubMed ID: 17912471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression.
    Kim A; Yang Y; Lee MS; Yoo YD; Lee HG; Lim JS
    Pigment Cell Melanoma Res; 2008 Dec; 21(6):653-64. PubMed ID: 19067970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hirseins inhibit melanogenesis by regulating the gene expressions of Mitf and melanogenesis enzymes.
    Villareal MO; Han J; Yamada P; Shigemori H; Isoda H
    Exp Dermatol; 2010 May; 19(5):450-7. PubMed ID: 19765058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sesamin induces melanogenesis by microphthalmia-associated transcription factor and tyrosinase up-regulation via cAMP signaling pathway.
    Jiang Z; Li S; Liu Y; Deng P; Huang J; He G
    Acta Biochim Biophys Sin (Shanghai); 2011 Oct; 43(10):763-70. PubMed ID: 21896570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A derivative of 2-aminothiazole inhibits melanogenesis in B16 mouse melanoma cells via glycogen synthase kinase 3β phosphorylation.
    Kim SY; Hahn HG; Nam KD; Park KC; Yun HY; Baek KJ; Kwon NS; Kim DS
    J Pharm Pharmacol; 2011 Aug; 63(8):1031-6. PubMed ID: 21718286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.